Abstract
By all demographic projections, the population 65 years of age and older will increase rapidly in absolute and relative numbers through the year 2020 and beyond. Although in the future the majority of older individuals will be healthy and able to function independently, a significant fraction will develop chronic health problems varying in degree from relatively minor difficulties to severe disabilities. Chronic diseases, and among those arthritis, will contribute prominently to disability. In a survey conducted in 1984 by the National Center for Health Statistics, arthritis ranked first among the 10 most prevalent chronic health problems, with a prevalence of 473 per 1,000 individuals 65 years and older and 495 per 1,000 individuals age 75 and above.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Felson DT, Naimark A, Anderson J, et al. The prevalence of knee osteoarthritis in the elderly: The Framingham Osteoarthritis Study. Arthritis Rheum 1987; 20. 30: 914–918.
Bergström G, Bjelle A, Sorensen LB, et al. Prevalence of rheumatoid arthritis, osteoarthritis, chondrocalcinosis 21. and gouty arthritis at age 79. J Rheum 1986; 13: 527–534.
Brandt KD. Osteoarthritis. Clin Geriatr Med 1988; 4: 279–293. 22.
Felson DT, Anderson JJ, Naimark A. Obesity and knee osteoarthritis. Ann Intern Med 1988; 109: 18–24.
Houpt JB, Pritzker KPH, Alpert B, et al. Natural history 23. of spontaneous osteonecrosis of the knee (SONK): A review. Semin Arthritis Rheum 1983; 13: 212–227.
Hall S, Bartleson JD, Onofrio BM, et al. Lumbar spinal 24. stenosis: Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med 1985; 103: 271–275. 25.
Hult L. Cervical, dorsal and lumbar spinal syndromes. A field investigation of a non-selected material of 1200 workers in different occupations with special reference 26. to disc degeneration and so-called muscular rheumatism. Acta Orthop Scand 1954;Suppl 17: 1–102.
Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti- 27. inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359–363.
Hollingworth P, Scott JT, Burry HC. Nonarticular gout: 28. Hyperuricemia and tophus formation without gouty arthritis. Arthritis Rheum 1983; 26: 98–101. 29.
Shmerling RH, Stern SH, Gravallese EM, et al. Tophaceous deposition in the finger pads without gouty arthritis. Arch Intern Med 1988; 148: 1830–1832.
Ellman MH, Brown ML, Levin B: Prevalence of knee 30. chondrocalcinosis in hospital and clinic patients aged 50 or older. J Am Geriatr Soc 1981; 29: 189–192.
Menkes CJ, Simon F, Delrieu F, et al. Destructive arthropathy in chondrocalcinosis. Arthritis Rheum 1976; 19 (Suppl): 329–348.
Reginato AJ, Schumacher HR: Crystal-associated arthropathies. Clin Geriatr Med 1988; 4: 295–322.
McCarty DJ, Halverson PB, Carrera GF, et al. Milwaukee shoulder association of microspheroids containing hydroxyapatite crystals, active collagenase and neutral protease with rotator cuff defects. I. Clinical aspects. Arthritis Rheum 1981; 24: 464–473.
Hunder GG, Hazleman BL. Giant cell arteritis and polymyalgia rheumatica. In: Kelley WN, Harrris ED, Ruddy S, Sledge CB, edts. Textbook of Rheumatology. Philadelphia: W.B. Saunders. 1985, pp 1166–1173.
Chuang T-Y, Hunder GG, Ilstrup DM, et al. Polymyalgia rheumatica: A 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672–680.
Machado EB, Michet CJ, Ballard DJ, et al. Temporal arteritis: An epidemiologic and clinical study. Arthritis Rheum 1987;30:No.4(Suppl) S50.
Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: A prospective investigation, 1982–1985. Arthritis Rheum 1987; 30: 294–299.
Ostberg G: On arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand 1973; 237 (Suppl A): 1–59.
Richardson JE, Gladman DD, Fam A, et al. HLA-DR4 in giant cell arteritis: Association with polymyalgia rheumatica syndrome. Arthritis Rheum 1987; 30: 1293–1297.
Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981; 24: 1414–1418.
Säve-Söderbergh J, Malmvall B-E, Andersson R, et al. Giant cell arteritis as a cause of death: Report of nine cases. JAMA 1986; 255: 493–496.
Ayoub WT, Franklin CM, Torretti T. Polymyalgia rheumatica: Duration of therapy and long-term outcome. Am J Med 1985; 79: 309–315.
Schmidt KL, Frencl V. Die rheumatoide Arthritis mit Beginn im höheren Lebensalter. Dtsch Med Wochenschr 1982; 107: 1506–1510.
Terkeltaub R, Esdaile J, Décary F, et al. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheum 1983; 10: 418–424.
Deal CL, Meenan RF, Goldenberg DL, et al. The clinical features of elderly-onset rheumatoid arthritis. Arthritis Rheum 1985; 28: 987–994.
McCarty DJ, O’Duffy JD, Pearson L, et al. Remitting seronegative symmetrical synovitis with pitting edema. JAMA 1985; 254: 2763–2767.
Steffe LA, Cooke CL. Still’s disease in a 70-year-old woman. JAMA 1983; 249: 2062–2063.
Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324.
Kean WF, Anastassiades TP, Dwash IL, et al. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly. J. Am Geriatr Soc 1982; 30: 94–100.
Mitchell DM, Spitz PW, Young DY, et al. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986; 29: 706–714.
Laakso M, Mitru O, Isomäki H, et al. Mortality from amyloidosis and renal disease in patients with rheumatoid arthritis. Ann Rheum Dis 1986; 45: 663–667.
Dimant J, Ginzler EM, Schlesinger M, et al. Systemic lupus erythematosus in the older age group: Computer analysis. J Am Geriatr Soc 1979; 27: 58–61.
Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus. Differences related to race and age of onset. Arthritis Rheum 1982; 25: 55–60.
Catoggio LJ, Skinner RP, Smith G, et al. Systemic lupus erythematosus in the elderly: Clinical and serological characteristics. J Rheum 1984; 11: 175–181.
Hochberg MC, Boyd RE, Ahearn JM, et al. Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985; 64: 285–295.
Baer AN, Pincus T. Occult systemic lupus erythematosus in elderly men. JAMA 1983; 249: 3350–3352.
Studenski S, Allen NB, Caldwell DS, et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 1987; 30: 1326–1331.
Medsger TA, Personal communication. Benedek TG. Neoplastic associations of rheumatic diseases and rheumatic manifestations of cancer. Clin Geriatr Med 1988;4:333–355.
Malinow KL, Molina R, Gordon B, et al. Neuropsychiatric dysfunction in primary Sjögren’s syndrome. Ann Intern Med 1985; 103: 344–349.
Alexander EL, Malinow K, Lejewski JE. Primary Sjögren’s syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 1986; 104: 323–330.
Medsger TA, Dixon JA, Garwood VF. Palmar fasciitis and polyarthritis associated with ovarian carcinoma. Ann Intern Med 1982; 96: 424–431.
Freundlich B, Makover D, Maul GG. A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome. Ann Intern Med 1988; 109: 295–297.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sorensen, L.B. (1990). Rheumatology. In: Cassel, C.K., Riesenberg, D.E., Sorensen, L.B., Walsh, J.R. (eds) Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2093-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2093-8_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2095-2
Online ISBN: 978-1-4757-2093-8
eBook Packages: Springer Book Archive